Skip to main content
Clinical Trials/NCT06866704
NCT06866704Not yet recruitingNot Applicable

Pulsed-Field Ablation Vs. Radiofrequency Ablation CombIned with Vein of Marshall Ethanol Ablation on Mitral Isthmus Block and Clinical Outcomes in Persistent Atrial Fibrillation: the PRIME-AF Randomized Clinical Trial

lingzhiyu0 sites154 target enrollmentStarted: April 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
154
Primary Endpoint
Immediate success rate of mitral isthmus ablation block

Study Overview

Brief Summary

Atrial fibrillation (AF) is one of the most common clinical arrhythmias, and catheter ablation serves as a critical therapeutic approach. For persistent atrial fibrillation, several proposed ablation strategies-including the 2C3L technique, BOX lesion sets, and substrate modification-remain highly controversial regarding long-term success rates. Multiple studies suggest that linear ablation beyond pulmonary vein isolation (PVI) often fails to achieve durable block due to incomplete ablation lines, which significantly contributes to postoperative recurrence of atrial arrhythmias.

In recent years, electrophysiologists have explored various methods to improve mitral isthmus (MI) ablation, such as combined endo-epicardial ablation and radiofrequency ablation (RFA) combined with Marshall vein alcohol ablation. While RFA combined with anhydrous alcohol injection into the Marshall vein enhances MI block rates, it is associated with prolonged procedure time, unpredictable ablation zones, and higher complication risks (e.g., coronary artery spasm, pericarditis).

Pulsed field ablation (PFA), an emerging non-thermal ablation technology, offers potential advantages such as tissue selectivity, shorter procedure time, and fewer complications. Studies report that RFA achieves near 100% immediate block rates; however, there is a lack of sufficient comparative studies on the efficacy and safety between these two ablation approaches. This study aims to compare the clinical outcomes and safety profiles of PFA versus RFA combined with Marshall vein alcohol injection in patients with persistent AF.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Persistent atrial fibrillation;
  • •Ejection fraction >30%;
  • •NYHA functional class I-III;
  • •Left atrial diameter <55 mm on echocardiography;
  • •Signed informed consent form;

Exclusion Criteria

  • •Pregnant or lactating women;
  • •Patients with a life expectancy of less than 2 years due to non-cardiovascular factors;
  • •Uncontrolled hyperthyroidism, severe liver or kidney dysfunction;
  • •History of atrial fibrillation ablation;
  • •History of heart transplantation, complex congenital heart disease, or rheumatic heart disease;
  • •Contraindications to contrast agents, radiofrequency ablation, antiarrhythmic drugs, or anticoagulants;
  • •Acute coronary syndrome, cardiac surgery, angioplasty, or cerebrovascular 8.accident within 12 weeks prior to enrollment;
  • •9.Other conditions deemed unsuitable for participation by investigators; 10.Participation in other clinical trials.

Arms & Interventions

pulsed field ablation

Experimental

patients receive pulsed field ablation (PFA) to achieve pulmonary vein isolation (PVI), circumferential BOX ablation around bilateral pulmonary veins, and mitral isthmus ablation.

Intervention: catheter ablation (Procedure)

EI-VOM

Placebo Comparator

anhydrous alcohol is first injected into the Marshall vein, followed by radiofrequency catheter ablation to complete PVI, BOX lesion sets, and mitral isthmus ablation.

Intervention: catheter ablation (Procedure)

Outcomes

Primary Outcomes

Immediate success rate of mitral isthmus ablation block

Time Frame: immediately after the procedure

Bidirectional MI block was confirmed by the following criteria: (1) proximal-to-distal CS activation pattern when pacing at the left lateral ridge; (2) longer SA interval at the left lateral ridge when pacing at the distal CS compared to pacing at the proximal CS

Mitral isthmus block rate

Time Frame: 20 minutes after the procedure

Bidirectional MI block was confirmed by the following criteria: (1) proximal-to-distal CS activation pattern when pacing at the left lateral ridge; (2) longer SA interval at the left lateral ridge when pacing at the distal CS compared to pacing at the proximal CS

Secondary Outcomes

  • time of operation(immediately after the procedure)
  • The incidence of atrial arrhythmias (tachycardia, atrial flutter, atrial fibrillation) over 30 seconds without antiarrhythmic drugs was followed up for 12 months.(1 year)
  • complication(2 weeks after the procedure)

Investigators

Sponsor
lingzhiyu
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

lingzhiyu

Director, Clinical Professor

The Second Affiliated Hospital of Chongqing Medical University

Similar Trials